| Price | $2.14 on 16-04-2026 at 05:00:10 |
|---|---|
| Change | $0.00 0% |
| Buy | $0.00 |
| Sell | $0.00 |
| Last Trade: | Buy 6,252.00 at $2.1403 |
| Day's Volume: | 0 |
| Last Close: | $2.14 |
| Open: | $0.00 |
| ISIN: | GG00BKTRRM22 |
| Day's Range | $0.00 - $0.00 |
| 52wk Range: | $1.12 - $2.32 |
| Market Capitalisation: | $695.66m |
| VWAP: | $0.00 |
| Shares in Issue: | 325.07m |
Rtw Biotech (RTW) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 6,252 | $2.1403 | SI Trade Negotiated Trade |
16:47:07 - 15-Apr-26 |
| Sell* | 69,478 | $2.14 | Uncrossing Trade |
16:35:29 - 15-Apr-26 |
| Unknown* | 251 | $2.158068 | Ordinary Currency Conversion |
16:25:10 - 15-Apr-26 |
| Buy* | 6,800 | $2.16 | Automatic Execution |
16:25:01 - 15-Apr-26 |
| Buy* | 863 | $2.16 | Automatic Execution |
16:24:56 - 15-Apr-26 |
| Buy* | 368 | $2.16 | Automatic Execution |
16:23:50 - 15-Apr-26 |
| Buy* | 619 | $2.16 | Automatic Execution |
16:23:39 - 15-Apr-26 |
| Buy* | 53 | $2.16 | Automatic Execution |
16:22:03 - 15-Apr-26 |
| Buy* | 27 | $2.16 | Automatic Execution |
16:22:03 - 15-Apr-26 |
| Buy* | 1,850 | $2.16 | Automatic Execution |
16:22:03 - 15-Apr-26 |
Rtw Biotech (RTW) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th Apr 2026 7:01 am | RNS | Obsidian Therapeutics reverse merger with Galera |
| 15th Apr 2026 7:00 am | RNS | Monthly Valuation Update and Factsheet |
| 8th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 7th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 2nd Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 1st Apr 2026 7:01 am | RNS | Total Voting Rights |
| 1st Apr 2026 7:00 am | RNS | Apellis and Centessa to be acquired |
| 31st Mar 2026 7:01 am | RNS | Transaction in Own Shares |
| 31st Mar 2026 7:00 am | RNS | Amani closes $25 million Series A financing |
| 30th Mar 2026 7:01 am | RNS | Transaction in Own Shares |
